Cargando…
The host interactome of influenza virus presents new potential targets for antiviral drugs
Increasing antiviral drug resistance is a major concern for treating influenza, especially in a pandemic setting when the availability of a protective vaccine is uncertain. Resistance is often an issue with drugs directed at viral proteins and for small RNA viruses; there are also a limited number o...
Autor principal: | Shaw, Megan L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207218/ https://www.ncbi.nlm.nih.gov/pubmed/21823192 http://dx.doi.org/10.1002/rmv.703 |
Ejemplares similares
-
Virus-host interactomics: new insights and opportunities for antiviral drug discovery
por: de Chassey, Benoît, et al.
Publicado: (2014) -
Virus–host interactomes — antiviral drug discovery
por: Ma-Lauer, Yue, et al.
Publicado: (2012) -
Severe fever with thrombocytopenia syndrome virus (SFTSV)-host interactome screen identifies viral nucleoprotein-associated host factors as potential antiviral targets
por: Cao, Jianli, et al.
Publicado: (2021) -
Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection
por: Lee, Suki Man-Yan, et al.
Publicado: (2012) -
Antiviral Drugs in Influenza
por: Świerczyńska, Magdalena, et al.
Publicado: (2022)